A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells
出版年份 2017 全文链接
标题
A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells
作者
关键词
-
出版物
OncoImmunology
Volume 7, Issue 1, Pages e1375641
出版商
Informa UK Limited
发表日期
2017-09-11
DOI
10.1080/2162402x.2017.1375641
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Highly specific and potently activating Vγ9Vδ2-T cell specific nanobodies for diagnostic and therapeutic applications
- (2016) Renée C.G. de Bruin et al. CLINICAL IMMUNOLOGY
- Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab
- (2016) Kilian Wistuba-Hamprecht et al. EUROPEAN JOURNAL OF CANCER
- Recombinant pharmaceuticals from microbial cells: a 2015 update
- (2016) Laura Sanchez-Garcia et al. Microbial Cell Factories
- Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy
- (2016) Oscar Murcia et al. WORLD JOURNAL OF GASTROENTEROLOGY
- RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor
- (2016) Zsolt Sebestyen et al. Cell Reports
- Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer
- (2016) John Pradeep Veluchamy et al. PLoS One
- Harnessing the power of Vδ2 cells in cancer immunotherapy
- (2015) D. W. Fowler et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Nanobody-based cancer therapy of solid tumors
- (2015) Marta Kijanka et al. Nanomedicine
- RAS testing in metastatic colorectal cancer: advances in Europe
- (2015) J Han JM Van Krieken et al. VIRCHOWS ARCHIV
- Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance
- (2015) Markus Morkel et al. Oncotarget
- Novel Bispecific Antibodies Increase T-Cell Cytotoxicity against Pancreatic Cancer Cells
- (2014) H.-H. Oberg et al. CANCER RESEARCH
- Primary and Acquired Resistance of Colorectal Cancer Cells to Anti-EGFR Antibodies Converge on MEK/ERK Pathway Activation and Can Be Overcome by Combined MEK/EGFR Inhibition
- (2014) T. Troiani et al. CLINICAL CANCER RESEARCH
- Bispecific antibody platforms for cancer immunotherapy
- (2014) Roeland Lameris et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells
- (2014) Andrew Sandstrom et al. IMMUNITY
- γδ T Cell-Mediated Immune Responses in Disease and Therapy
- (2014) T. Sree Latha et al. Frontiers in Immunology
- Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery
- (2013) Marta Kijanka et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A Quantitative Deficiency in Peripheral Blood Vγ9Vδ2 Cells Is a Negative Prognostic Biomarker in Ovarian Cancer Patients
- (2013) Aurélie Thedrez et al. PLoS One
- Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains
- (2013) Karl R. Schmitz et al. STRUCTURE
- Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study
- (2013) Sakarias Wangefjord et al. Biology of Sex Differences
- Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity
- (2013) Dieter Kabelitz et al. OncoImmunology
- 9 and 2CDR3 domains regulate functional avidity of T cells harboring 9 2TCRs
- (2012) C. Grunder et al. BLOOD
- Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human T-cell subset
- (2012) C. Harly et al. BLOOD
- What lessons can be learned from γδ T cell-based cancer immunotherapy trials?
- (2012) Jean-Jacques Fournié et al. Cellular & Molecular Immunology
- The Molecular Basis for Modulation of Human Vγ9Vδ2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific Antibodies
- (2012) Aparna Palakodeti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- KRAS and BRAF Mutation Analysis in Routine Molecular Diagnostics
- (2012) Daniëlle A.M. Heideman et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas
- (2012) Adriana Cordova et al. PLoS One
- Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
- (2011) A J Nicol et al. BRITISH JOURNAL OF CANCER
- A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth
- (2011) Rob C. Roovers et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors
- (2011) Yevgeniy Balagula et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Retargeting of Human Regulatory T Cells by Single-Chain Bispecific Antibodies
- (2011) S. Koristka et al. JOURNAL OF IMMUNOLOGY
- Use of a Collagen–Elastin Matrix as Transport Carrier System to Transfer Proliferating Epidermal Cells to Human Dermis in Vitro
- (2010) Taco Waaijman et al. CELL TRANSPLANTATION
- γ δ T Cell Modulation in Anticancer Treatment
- (2010) N. Caccamo et al. CURRENT CANCER DRUG TARGETS
- Harnessing the immune response to treat cancer
- (2010) H J Steer et al. ONCOGENE
- T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells
- (2010) Ralf Lutterbuese et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Production of recombinant proteins by microbes and higher organisms
- (2009) Arnold L. Demain et al. BIOTECHNOLOGY ADVANCES
- KRASandBRAFMutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
- (2009) Susan D. Richman et al. JOURNAL OF CLINICAL ONCOLOGY
- Secreted Gaussia Luciferase as a Biomarker for Monitoring Tumor Progression and Treatment Response of Systemic Metastases
- (2009) Euiheon Chung et al. PLoS One
- Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology
- (2008) B. M. Tijink et al. MOLECULAR CANCER THERAPEUTICS
- A secreted luciferase for ex vivo monitoring of in vivo processes
- (2008) Thomas Wurdinger et al. NATURE METHODS
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now